Your session is about to expire
← Back to Search
LithoVue Elite Ureteroscope for Kidney Stones (LVE Trial)
LVE Trial Summary
This trial will test a new type of ureteroscope that has pressure-sensing ability. The goal is to see if this new scope can reduce pain and complications related to kidney stones.
LVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLVE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LVE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have kidney abnormalities.I am older than 18 years.I am under 18 years old.I am scheduled for a procedure to remove kidney stones using lasers.You are pregnant.I have a kidney stone smaller than 2 cm and am getting a flexible ureteroscopy.I have severe kidney swelling that makes treating my kidney stones difficult.You have a tube in your kidney to help drain urine.
- Group 1: Ureteroscopy (URS) with the LithoVue Elite disposable flexible ureteroscope
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the primary goal of this medical experiment?
"The primary objective of this medical trial, which will be evaluated at the conclusion of a surgical procedure, is to measure WISQOL. Additionally, an assessment of Stone free rate through imaging, BPI by means of the Brief Pain Inventory Questionnaire (BPI), and Postoperative infectious Complications as reported by healthcare providers are also monitored for secondary outcomes."
Are there any vacancies within this clinical trial for participants?
"The entry for this clinical trial on the website of clinicaltrials.gov reveals that recruitment has ceased; it was initially posted on January 15th, 2023 and last updated November 10th 2022. Nevertheless, there are presently 88 other trials actively looking for participants."
How widespread is the implementation of this experiment?
"This trial is conducted at 6 different sites, with the most prominently being Western University in London, CHU de Québec-Université Laval in Québec City and Hôpital Maisonneuve-Rosemont (HMR) located in Montréal-Est. The remaining 3 locations are less well known."
Share this study with friends
Copy Link
Messenger